As of 2025-07-07, the Relative Valuation of Altimmune Inc (ALT) is (19.23) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.76 USD, the upside of Altimmune Inc based on Relative Valuation is -504.0%.
The range of the Relative Valuation is (13.86) - (26.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 18.7x | 13.1x |
| Forward P/E multiples | 9.7x - 21.3x | 13.7x |
| Fair Price | (13.86) - (26.78) | (19.23) |
| Upside | -391.3% - -662.6% | -504.0% |
| Date | P/E |
| 2025-07-03 | -3.32 |
| 2025-07-02 | -3.41 |
| 2025-07-01 | -2.95 |
| 2025-06-30 | -2.70 |
| 2025-06-27 | -2.44 |
| 2025-06-26 | -2.52 |
| 2025-06-25 | -5.37 |
| 2025-06-24 | -5.01 |
| 2025-06-23 | -4.87 |
| 2025-06-20 | -4.90 |
| 2025-06-18 | -4.72 |
| 2025-06-17 | -4.80 |
| 2025-06-16 | -4.79 |
| 2025-06-13 | -4.82 |
| 2025-06-12 | -4.98 |
| 2025-06-11 | -4.56 |
| 2025-06-10 | -4.70 |
| 2025-06-09 | -4.15 |
| 2025-06-06 | -3.92 |
| 2025-06-05 | -3.80 |
| 2025-06-04 | -3.83 |
| 2025-06-03 | -3.78 |
| 2025-06-02 | -3.69 |
| 2025-05-30 | -3.78 |
| 2025-05-29 | -3.91 |
| 2025-05-28 | -3.83 |
| 2025-05-27 | -3.84 |
| 2025-05-23 | -3.98 |
| 2025-05-22 | -4.02 |
| 2025-05-21 | -3.89 |
| 2025-05-20 | -4.08 |
| 2025-05-19 | -3.83 |
| 2025-05-16 | -3.89 |
| 2025-05-15 | -4.03 |
| 2025-05-14 | -3.97 |
| 2025-05-13 | -4.01 |
| 2025-05-12 | -4.19 |
| 2025-05-09 | -3.89 |
| 2025-05-08 | -4.04 |
| 2025-05-07 | -3.73 |
| 2025-05-06 | -3.50 |
| 2025-05-05 | -3.78 |
| 2025-05-02 | -4.02 |
| 2025-05-01 | -3.60 |
| 2025-04-30 | -3.66 |
| 2025-04-29 | -3.55 |
| 2025-04-28 | -3.53 |
| 2025-04-25 | -3.53 |
| 2025-04-24 | -3.60 |
| 2025-04-23 | -3.46 |